Clinical and molecular study of DiGeorge sequence.
DiGeorge sequence (DGS) is a developmental field defect of the third and fourth pharyngeal pouches. The cardinal features of the syndrome are hypo- or aplasia of the thymus and parathyroids, congenital heart defect of the conotruncal type and characteristic facial dysmorphism. Such a pattern of malformations has been associated with various conditions but it is now well established that most cases of DGS are due to haplo-insufficiency of the chromosome 22q11 region. We report here a series of 16 patients, including a familial case. Minimal criteria for inclusion in this series were two or more of the following features: conotruncal heart defect, hypocalcaemia, hypoplastic/absent thymus and typical facial dysmorphism. Molecular analysis with specific probes of the 22q11 region was conducted in all patients according to two methods, fluorescent in situ hybridization and DNA dosage analysis. A deletion was found at the molecular level in all patients. We emphasize the fact that clinical analysis remains an important step of the diagnosis. The implication of these molecular techniques on diagnosis, prognosis and genetic counselling of DGS are discussed.
Levy-Mozziconacci
A
A
Department of Paediatrics and Medical Genetics, Hôpital d'Enfants de la Timone, Marseilles, France.
Wernert
F
F
Scambler
P
P
Rouault
F
F
Metras
D
D
Kreitman
B
B
Depetris
D
D
Mattei
M G
MG
Philip
N
N
D002675:Child, Preschool; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics*; D015342:DNA Probes; D004062:DiGeorge Syndrome / Q000235:genetics*; D005260:Female; D017353:Gene Deletion; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007223:Infant; D007231:Infant, Newborn; D008297:Male
D015342:DNA Probes